Abstract
In this study the authors compared the levels of glutamine synthetase (GS) enzymatic activities, as well as the levels of immunoreactive GS and GS-like protein (GSLP) in the readily soluble protein fraction of brain samples taken during autopsies of patients with schizophrenia and subjects from a control group. Enzymatic GS activity was measured and levels of immunoreactive GS and GSLP were determined in postmortem samples of the prefrontal, anterior, and posterior cingulate cortex (Brodmann areas 10, 24, and 23, respectively) and cerebellum cortex obtained from patients with schizophrenia (n = 8) and a control group (n = 9), matched according to age and postmortem interval. GS activity was evaluated in vitro in the “transferase” reaction by the formation of γ-glutamyl hydroxamate, and the levels of immunoreactive GS and GSLP were evaluated by ECL Western blotting using monoclonal and polyclonal antibodies. No differences in GS enzymatic activity were found in all of the studied brain structures. The level of immunoreactive GS in the prefrontal cortex was significantly decreased in patients with schizophrenia compared with the controls (at p < 0.001 according to the Mann–Whitney U-test); it was unchanged in the posterior cingulate cortex and significantly elevated in the anterior cingulate cortex and cerebellum (p < 0.001 and p < 0.004, respectively), whereas the level of immunoreactive GSLP was elevated in all studied brain areas (p < 0.004, p < 0.02, p < 0.04, and p < 0.006, respectively). The alteration of GS and GSLP levels in brains of patients with schizophrenia is one of the factors that disturb glutamate metabolism in these brain structures and is an important aspect of schizophrenia pathogenesis.
Similar content being viewed by others
References
Altamura, C., Fagiolini, A., Galderisi, S., Rocca, P., and Rossi, A., J. Psychopathol., 2014, vol. 20, pp. 223–243.
Messias, E., Chen, C.-Y., and Eaton, W.W., Psychiatr. Clin. North. Am., 2007, vol. 30, no. 3, pp. 323–338.
Kim, J.S., Kornhuber, H.H., Schmid-Burgk, W., and Holzmüller, B., Neurosci. Lett., 1980, vol. 20, no. 3, pp. 379–382.
Bartha, R., Williamson, P.C., and Drost, D.J., Arch. Gen. Psychiatry, 1997, vol. 54, pp. 959–965.
Krystal, J.H., Belger, A., D’Souza, D.C., Amit, A., Charney, D.S., Aghajanian, G.K., and Moghaddam, B., Neuropsychopharmacology, 1999, vol. 21, pp. 143–157.
Gluck, M.R., Thomas, R.G., Davis, K.L., and Haroutunian, V., Am. J. Psychiatry, 2002, vol. 159, pp. 1165–1173.
Tamminga, C.A. and Frost, D.O., Am. J. Psychiatry, 2001, vol. 158, pp. 1365–1366.
Coyle, J.T., Schizophr. Bull., 2012, vol. 38, no. 5, pp. 920–926.
Tapiero, H., Mathe, G., Couvreur, P., and Tew, K.D., Biomed. Pharmacother., 2002, vol. 56, pp. 446–457.
Boksha, I.S., Biochemistry (Moscow), 2004, vol. 69, pp. 705–719.
Boksha, I.S., Specific Metabolism of Glutamate in Schizophrenia, Saarbrucken, Germany: LAP Lambert Academic Publishing, 2012, pp. 1–189.
Tsakopoulos, M. and Magistretti, P.J., J. Neurosci., 1996, vol. 16, pp. 877–885.
McKenna, M.C., Stevenson, J.H., Huang, X., and Hopkins, I.B., Neurochem. Int., 2000, vol. 37, pp. 229–241.
Cooper, A.J. and Jeitner, T.M., Biomolecules, 2016, vol. 26, no. 6 (2), pp. 16–49.
Bernstein, H.G., Tausch, A., Wagner, R., Steiner, J., Seeleke, P., Walter, M., Dobrowolny, H., and Bogerts, B., CNS Neurol. Disord. Drug Targets, 2013, vol. 12, pp. 900–913.
Schousboe, A.A., Neurochem. Res., 2017, vol. 42, no. 1, pp. 4–9.
Derouiche, A. and Frotscher, M., Brain Res., 1991, vol. 552, no. 2, pp. 346–350.
Yamamoto, H., Konno, H., Yamamoto, T., Ito, K., Mizugaki, M., and Iwasaki, Y., J. Neurochem., 1987, vol. 49, no. 2, pp. 603–609.
Tumani, H., Shen, G.Q., and Peter, J.B., J. Immunol. Methods, 1995, vol. 188, pp. 155–163.
Boksha, I.S., Tereshkina, E.B., and Burbaeva, G.Sh., J. Neurochem., 2000, vol. 75, pp. 2574–2582.
Boksha, I.S., Tereshkina, E.B., and Burbaeva, G.Sh., Biochemistry (Moscow), 1995, vol. 10, pp. 1299–1304.
Boksha, I.S., Schönfeld, H.-J., Langen, H., Müller, F., Tereshkina, E.B., and Burbaeva, G.Sh., Biochemistry (Moscow), 2002, vol. 67, pp. 1012–1020.
Gunnersen, D. and Haley, B., Proc. Natl. Acad. Sci. U.S.A., 1992, vol. 89, pp. 11949–11953.
Carney, J.M., Smith, C.D., Carney, A.M., and Butterfield, D.A., Ann. NY Acad. Sci., 1994, vol. 738, pp. 44–53.
Le Prince, Gh., Delaere, P., Fages, Ch., Lefrancois, Th., Touret, M., Salanon, M., and Tardy, M., Neurochem. Res., 1995, vol. 20, pp. 859–862.
Tereshkina, E.B., Boksha, I.S., Savushkina, O.K., and Burbaeva, G.Sh., Zh. Nevrol. Psikhiatr. im. S.S. Korsakova (Russia), 2000, vol. 100, pp. 51–53.
Burbaeva, G.S., Boksha, I.S., Tereshkina, E.B., Savushkina, O.K., Starodubtseva, L.I., Turishcheva, M.S., and Mukaetova-Ladinska, E.B., Neurochem. Res., 2007, vol. 32, no. 9, pp. 1434–1444.
Burbaeva, G.Sh., Boksha, I.S., Turishcheva, M.S., Vorobyeva, E.B., Savushkina, O.K., and Tereshkina, E.B., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2003, vol. 27, pp. 675–680.
Smesny, S., Gussew, A., Biesel, N.J., Schack, S., Walther, M., Rzanny, R., Milleit, B., Gaser, C., Sobanski, T., Schultz, C.C., Amminger, P., Hipler, U.C., Sauer, H., and Reichenbach, J.R., Schizophr. Res., 2015, vol. 168, no. 1–2, pp. 322–329.
Kristiansen, L.V., Beneyto, M., Haroutunian, V., and Meador-Woodruff, J.H., Mol. Psychiatry, 2006, vol. 11, no. 8, pp. 737–747.
Funk, A.J., Rumbaugh, G., Harotunian, V., McCullumsmith, R.E., and Meador-Woodruff, J.H., Neuroreport, 2009, vol. 20, no. 11, pp. 1019–1022.
Kozlovskiy, S.A., Velichkovsky, B.B., Vartanov, A.V., Nikonova, E.Yu., and Velichkovsky, B.M., Experimental’naya Psikhologiya (Russia), 2012, vol. 5, pp. 12–22.
Choi, J.S., Kang, D.H., Kim, J.J., Ha, T.H., Roh, K.S., Youn, T., and Kwon, J.S., Psychiatry Res., 2005, vol. 139, no. 3, pp. 239–247.
Koo, M.S., Levitt, J.J., Salisbury, D.F., Nakamura, M., Shenton, M.E., and McCarley, R.W., Arch. General. Psychiatry, 2008, vol. 65, no. 7, pp. 746–760.
Mitelman, S.A., Shihabuddin, L., Brickman, A.M., Hazlett, E.A., and Buchsbaum, M.S., Schizophrenia Res., 2005, vol. 72, nos. 2–3, pp. 91–108.
Vostrikov, V.M., Artiukhova, O.A., Kholmova, M.A., Samorodov, A.V., and Uranova, N.A., Zh. Nevrol. Psikhiatr. im S.S. Korsakova, 2013, vol. 113, pp. 67–70.
Diamond, A., Child. Dev., 2000, vol. 71, no. 1, pp. 44–56.
Bolbecker, A.R., Petersen, I.T., Kent, J.S., Howell, J.M., O’Donnell, B.F., and Hetrick, W.P., Front. Psychiatry, 2016, vol. 25, no. 7, p.4.
Bottmer, C., Bachmann, S., Pantel, J., Essig, M., Amann, M., Schad, L.R., Magnotta, V., and Schröder, J. Psychiatry Res., 2005, vol. 140, no. 3, pp. 239–250.
Rasser, P.E., Schall, U., Peck, G., Cohen, M., Johnston, P., Khoo, K., Carr, V.J., Ward, P.B., and Thompson, P.M., Neuroimage, 2010, vol. 53, no. 4, pp. 1175–1180.
Ichimiya, T., Okubo, Y., Suhara, T., and Sudo, Y., Biol. Psychiatry, 2001, vol. 49, no. 1, pp. 20–27.
Iqbal, K. and Ottaway, J.H., Biochem., 1970, vol. 119, pp. 145–156.
Laemmli, U., Nature, 1970, vol. 227, pp. 680–685.
Egerton, A., Brugger, S., Raffin, M., Barker, G.J., Lythgoe, D.J., McGuire, P.K., and Stone. J.M., Neuropsychopharmacology, 2012, vol. 37. no. 11, pp. 2515–2521.
de la Fuente-Sandoval C León-Ortiz, P., Azcárraga, M., Stephano, S., Favila, R., Díaz-Galvis, L., Alvarado-Alanis, P., Ramírez-Bermúdez, J., and Graff-Guerrero, A., JAMA Psychiatry, 2013, vol. 70, no. 10, pp. 1057–1066.
Merritt, K., McGuire, P., and Egerton, A., Front. Psychiatry, 2013, vol. 26, no. 4, p.151.
Schobel, S.A., Chaudhury, N.H., Khan, U.A., Paniagua, B., Styner, M.A., Asllani, I., Inbar, B.P., Corcoran, C.M., Lieberman, J.A., Moore, H., and Small, S.A., Neuron, 2013, vol. 78, no. 1, pp. 81–93.
Oni-Orisan, A., Kristiansen, L.V., Haroutunian, V., Meador-Woodruff, J.H., and McCullumsmith, R.E., Biol. Psychiatry, 2008, vol. 63, no. 8, pp. 766–775.
Stone, J.M., Ther. Adv. Psychopharmacol., 2011, vol. 1, no. 1, pp. 5–18.
Mattson, M.P., Ann. NY Acad. Sci., 2008, vol. 1144, pp. 97–112.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.S. Boksha, E.B. Tereshkina, O.K. Savushkina, T.A. Prokhorova, E.A. Vorobyeva, G.Sh. Burbaeva, 2018, published in Neirokhimiya, 2018, Vol. 35, No. 1, pp. 88–95.
The article was translated by the authors.
Rights and permissions
About this article
Cite this article
Boksha, I.S., Tereshkina, E.B., Savushkina, O.K. et al. Comparative Studies of Glutamine Synthetase Levels in the Brains of Patients with Schizophrenia and Mentally Healthy People. Neurochem. J. 12, 95–101 (2018). https://doi.org/10.1134/S1819712418010026
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712418010026